Monopar Therapeutics Reports Second Quarter 2024 Financial Results and Recent Developments

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/24/2026

1. JMKE
2. NVDA
3. SPY
4. BABA
5. REF
6. USO
7. XPEV
8. CAPR
9. TSLA
10. FUL

Go back to Monopar Therapeutics Reports Second Quarter 2024 Financial Results and Recent Developments
(NASDAQ: MNPR) Delayed: 108.38 +0.66 (0.61%)
Previous Close $107.72    52 Week High $ 
Open $106.99    52 Week Low $ 
Day High $110.61    P/E N/A 
Day Low $104.48    EPS $ 
Volume 148,290